OLO Form 4: Director Daniel Meyer reports sale and trust holdings
Rhea-AI Filing Summary
Reporting person: Daniel H. Meyer, a director of Olo Inc. (OLO). The Form 4 shows a sale of 6,000 shares of Class A common stock on 08/12/2025 at a weighted average price of $10.2005 per share. The filing discloses additional positions: 125,324 shares reported as directly beneficially owned, 470,275 shares held indirectly by The Daniel H. Meyer Investment Trust, and 348,270 shares held indirectly by the DHM 2012 Gift Trust. The report includes disclaimers that certain shares are disclaimed as beneficially owned except to the extent of pecuniary interest and that some shares are held by the reporting person’s child.
Positive
- Continued material ownership: The reporting person maintains substantial holdings via direct and trust accounts (125,324 direct; 470,275 and 348,270 indirect).
- Clear disclosure: The filing provides transaction price details (weighted average) and explicit disclaimers about trust and child-held shares.
Negative
- Insider sale: The director sold 6,000 shares on 08/12/2025 at a weighted average price of $10.2005.
Insights
TL;DR: Director sold a small block of OLO stock while retaining sizeable direct and indirect holdings, indicating ongoing material ownership.
The 6,000-share sale at a weighted average price of $10.2005 is a disclosed Section 16 transaction and appears relatively small compared with the positions reported in trusts and direct ownership. The filing documents multiple ownership forms including direct, indirect via an investment trust, and indirect via a gift trust, each with explicit disclaimers of beneficial ownership except for pecuniary interest. For investors, this is a routine insider sale disclosure rather than an unusual corporate action; it provides transparency on the director’s ongoing economic exposure.
TL;DR: The Form 4 is a standard required disclosure: a small sale and clear trust structures with disclaimers are reported.
The report clearly identifies the reporting person as a director and lists the relationships and ownership vehicles. The explanatory footnotes specify the sale price range and the trust arrangements, and include standard disclaimers regarding beneficial ownership. There are no disclosures of new grants, exercises, or derivative transactions, and no amendments noted; the filing fulfills routine Section 16 transparency obligations without signaling governance or control changes.